ESLA

Estrella Immunopharma

0.4994

-0.0028-0.56%

Opening13:05 09/22 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.5020/0.5022

TODAY RANGE0.4994-0.5595

VOL40.40K

MARKET CAP21.72M

52 WEEK RANGE0.4994-3.150

AVG VOL (3M)41.48K

% TURNOVER0.08%

TURNOVER--

P/E (TTM)-1.9692

% RANGE11.97%

EPS(TTM)-0.2536

P/E(FORWARD)-1.4269

P/B-2.8917

BVPS-0.1727

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP8.60M

SHARES OUTSTANDING43.50M

NEXT EARNINGS11/10-11/16

FREE FLOAT17.22M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·09/08 22:11
Estrella Immunopharma Faces Nasdaq Listing Compliance Challenge
NASDAQ·08/12 05:26
Estrella Adds Cleveland Site To STARLIGHT-1 Trial For B-cell Lymphoma; Stock Up
TipRanks·08/11 12:06
Estrella Immunopharma activates fourth clinical site for STARLIGHT-1 trial
TipRanks·08/03 12:05
Estrella Immunopharma activates third trial site for Starlight-1 trial
TipRanks·07/29 12:10
Estrella Immunopharma activates second clinical site for STARLIGHT-1 trial
TipRanks·07/24 12:05
Estrella announces first patient dosed in STARLIGHT-1 Phase I/II trial
TipRanks·06/30 21:54
Estrella Immunopharma Shareholders Ratify 2026 Auditor Appointment
Dow Jones·02/09 12:40
Estrella Immunopharma Is Maintained at Buy by D. Boral Capital
Dow Jones·02/09 12:40
Estrella Immunopharma Price Target Maintained With a $8.00/Share by D. Boral Capital
TipRanks·02/09 12:21
Estrella Immunopharma presents updated data on EB103
Dow Jones·01/28 12:14
Estrella Immunopharma Is Maintained at Buy by D. Boral Capital
Dow Jones·01/28 12:14
Estrella Immunopharma Price Target Cut to $8.00/Share From $16.00 by D. Boral Capital
TipRanks·01/13 22:48
Estrella Immunopharma Receives Nasdaq Non-Compliance Notice
TipRanks·01/06 21:40
Estrella Immunopharma completes $8M direct offering financing
TipRanks·12/04/2025 14:47
Estrella Immunopharma Advances STARLIGHT-1 Trial to Phase II

Same Industry

Name/Symbol

Change%

Price

REGN

GridAI Tech

GRDX

+5.59%

3.590

BIONTECH

BNTX

+2.02%

98.00

United Therapeutics Corp.

UTHR

-0.31%

493.10

Vertex Pharmaceuticals Inc

VRTX

-1.55%

508.34

Siga Technologie

SIGA

+2.95%

3.140

Moderna

MRNA

+9.74%

169.04

Charles Riv Labs Intl Inc

CRL

-1.28%

278.06

MEDP

TLPH

ICON plc

ICLR

+3.31%

169.55

CBPO

IQV

MOLN

Arcturus Therape

ARCT

-5.32%

16.03

Gilead Sciences Inc

GILD

-0.52%

150.11

PRAH

Incyte Corp

INCY

-0.53%

124.65

Aptevo Therapeutics Inc

APVO

0.00%

1.840

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.